Denali Therapeutics Stock Is Sliding After The Bell Heres Why
| DNLI Stock | USD 14.29 0.38 2.73% |
Under 54% of Denali Therapeutics' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Denali Therapeutics suggests that some traders are interested. Denali Therapeutics' investing sentiment shows overall attitude of investors towards Denali Therapeutics.
Denali Therapeutics shares are moving lower in Thursdays after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued.
Read at benzinga.com
 |
Denali Therapeutics Fundamental Analysis
We analyze Denali Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Denali Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Denali Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Denali Therapeutics is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Denali Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Denali Therapeutics stock to make a market-neutral strategy. Peer analysis of Denali Therapeutics could also be used in its relative valuation, which is a method of valuing Denali Therapeutics by comparing valuation metrics with similar companies.
Peers
Denali Therapeutics Related Equities
| AKRO | Akero Therapeutics | 24.72 | ||||
| PCVX | Vaxcyte | 14.17 | ||||
| FDMT | 4D Molecular | 10.47 | ||||
| LEGN | Legend Biotech | 4.79 | ||||
| RNA | Avidity Biosciences | 4.70 | ||||
| DSGN | Design Therapeutics | 3.97 | ||||
| TVTX | Travere Therapeutics | 3.23 | ||||
| BDTX | Black Diamond | 2.84 | ||||
| STOK | Stoke Therapeutics | 2.24 | ||||
| IKNA | Ikena Oncology | 1.80 | ||||
| HOWL | Werewolf Therapeutics | 1.79 | ||||
| BPMC | Blueprint Medicines | 1.76 | ||||
| ASND | Ascendis Pharma | 1.73 | ||||
| DAWN | Day One | 1.54 | ||||
| RVMD | Revolution Medicines | 1.35 | ||||
| APLS | Apellis Pharmaceuticals | 1.26 | ||||
| GLUE | Monte Rosa | 1.22 | ||||
| SWTX | SpringWorks Therapeutics | 0.09 |
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |